Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $2000.0000 (33.33%) ($2000.0000 - $2500.0000) on Thu. Sep. 20, 2007. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 16.1% (three month average) | RSI | 0 | Latest Price | $2000.0000(33.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 16.1% a day on average for past five trading days. | Weekly Trend | CAPR advances 20.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWJ(0%) FXI(-0%) IWM(0%) OIH(0%) PEJ(-0%) | Factors Impacting CAPR price | CAPR will decline at least -8.05% in a week (0% probabilities). GLD(-4%) TLT(-3%) TIP(-3%) XLU(-2%) EWP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -8.05% (StdDev 16.1%) | Hourly BBV | 0 () | Intraday Trend | -20% | | | |
|
5 Day Moving Average | $1410(41.84%) | 10 Day Moving Average | $1233.41(62.15%) | 20 Day Moving Average | $1130.57(76.9%) | To recent high | 0% | To recent low | 247.8% | Market Cap | $39.395b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |